+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

Phosphatidylinositol 3-Kinase (PI3K) Inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Phosphatidylinositol 3-Kinase (PI3K) Inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 80 Pages
  • Global
From
Hematopoietic progenitor kinase 1 inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Hematopoietic progenitor kinase 1 inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
From
From
From
Hedgehog Pathway Inhibitors Market 2024-2028 - Product Thumbnail Image

Hedgehog Pathway Inhibitors Market 2024-2028

  • Report
  • October 2024
  • 143 Pages
  • Global
From
Janus Kinase (JAK) Inhibitors Market 2024-2028 - Product Thumbnail Image

Janus Kinase (JAK) Inhibitors Market 2024-2028

  • Report
  • October 2024
  • 145 Pages
  • Global
From
NTRK Fusion Gene Positive Advanced Solid Tumor Market 2024-2028 - Product Thumbnail Image

NTRK Fusion Gene Positive Advanced Solid Tumor Market 2024-2028

  • Report
  • August 2024
  • 123 Pages
  • Global
From
Laryngeal Cancer Therapeutics Market 2024-2028 - Product Thumbnail Image

Laryngeal Cancer Therapeutics Market 2024-2028

  • Report
  • August 2024
  • 170 Pages
  • Global
From
Non-hodgkin Lymphoma (NHL) Therapeutics Market 2024-2028 - Product Thumbnail Image

Non-hodgkin Lymphoma (NHL) Therapeutics Market 2024-2028

  • Report
  • July 2024
  • 190 Pages
  • Global
From
Non-melanoma Skin Cancer Market 2024-2028 - Product Thumbnail Image

Non-melanoma Skin Cancer Market 2024-2028

  • Report
  • July 2024
  • 145 Pages
  • Global
From
Gemcitabine Hydrochloride Market 2024-2028 - Product Thumbnail Image

Gemcitabine Hydrochloride Market 2024-2028

  • Report
  • July 2024
  • 132 Pages
  • Global
From
Gastric Cancer Drugs Market 2024-2028 - Product Thumbnail Image

Gastric Cancer Drugs Market 2024-2028

  • Report
  • June 2024
  • 168 Pages
  • Global
From
Bispecific Antibodies for Cancer Market 2024-2028 - Product Thumbnail Image

Bispecific Antibodies for Cancer Market 2024-2028

  • Report
  • June 2024
  • 172 Pages
  • Global
From
Colorectal Cancer Therapeutics Market 2024-2028 - Product Thumbnail Image

Colorectal Cancer Therapeutics Market 2024-2028

  • Report
  • June 2024
  • 146 Pages
  • Global
From
Car T-Cell Therapy Market 2024-2028 - Product Thumbnail Image

Car T-Cell Therapy Market 2024-2028

  • Report
  • June 2024
  • 162 Pages
  • Global
From
Oral Cancer Therapeutics Market 2024-2028 - Product Thumbnail Image

Oral Cancer Therapeutics Market 2024-2028

  • Report
  • June 2024
  • 143 Pages
  • Global
From
Liver Cancer Drugs Market 2024-2028 - Product Thumbnail Image

Liver Cancer Drugs Market 2024-2028

  • Report
  • June 2024
  • 142 Pages
  • Global
From
Head and Neck Cancer Treatment Market 2024-2028 - Product Thumbnail Image

Head and Neck Cancer Treatment Market 2024-2028

  • Report
  • June 2024
  • 165 Pages
  • Global
From
Lung Cancer Therapeutics Market 2024-2028 - Product Thumbnail Image

Lung Cancer Therapeutics Market 2024-2028

  • Report
  • May 2024
  • 171 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more